Targeting the National Institutes of Health network of academic centers, like UCI, that are recipients of Clinical and Translational Science Award (CTSA, led by the National Center for Advancing Translational Sciences) hubs across the nation, the call-to-action includes: Build and support multidisciplinary teams of frontline clinicians, community partners, physiologists and behavioral and pharmaceutical scientists to address the knowledge gap in GLP-1RA effects in children and adolescents
E11.65 Type 2 diabetes mellitus with hyperglycemia Use when: The patient has high blood sugar or poor glycemic control, and the provider documents hyperglycemia or poor control. Importance: This code provides stronger payer justification as it shows poor glycemic control
Diabetic kidney disease: challenges, progress, and possibilities
We assessed the risk of suicide or suicide attempts following initiation of GLP-1 RA, DPP-4 inhibitors or SGLT-2 inhibitors, respectively
69%), and have lower CCI scores (2.55 vs